Investing.com - IDEXX Labs reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
IDEXX Labs announced earnings per share of $1.83 on revenue of $801.09M. Analysts polled by Investing.com EPS of $1.72 on revenue of $781.83M.
IDEXX Labs 's are up 3% and is trading at $513.51 , still down 27.32% from its 52 week high of $706.51 set on Wednesday, August 4, 2021.
IDEXX Labs follows other major Healthcare sector earnings this month
IDEXX Labs's report follows an earnings beat by J&J on Tuesday, January 25, 2022, who reported EPS of $2.13 on revenue of $24.8B, EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on Wednesday, January 19, 2022 with fourth quarter EPS of $4.48 on revenue of $73.74B, for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar